In the context of malignant transformation from islet cells to pancreatic neuroendocrine tumors (PanNETs), there is often overexpression of AKT and the presence of mutations in the AKT/mTOR pathway23. The gene discussed is MTOR; the disease is pancreatic neuroendocrine tumor.